Microba Life Sciences LimitedASX: MAP

MAP: Proposed Merger with GSS not proceeding

· Issued by Microba Life Sciences Limited via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Microba is currently exploring funding options while in voluntary suspension of trading. This outcome is disappointing after months of discussions and due diligence regarding the merger.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Announcement 18 November 2026 Proposed Merger with Genetic Signatures Limited not proceeding Microba Life Sciences Limited (ASX: MAP) (“Microba” or “the Company”) refers to previous announcements relating to the proposed merger between Genetic Signatures Limited (ASX: GSS) (GSS) and...

Microba Life Sciences Limited on 6ix

Story so far

Earlier from Microba Life Sciences

Later from Microba Life Sciences

All Microba Life Sciences news releases